ArticleOncoTargets and therapy2018

miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells.

Kankan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.